BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 6455963)

  • 1. Isoniazid-induced elevation of CSF GABA levels and effects on chorea in Huntington's disease.
    Manyam BV; Katz L; Hare TA; Kaniefski K; Tremblay RD
    Ann Neurol; 1981 Jul; 10(1):35-7. PubMed ID: 6455963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of isoniazid on cerebrospinal fluid and plasma GABA levels in Huntington's disease.
    Manyam NV; Hare TA; Katz L
    Life Sci; 1980 Apr; 26(16):1303-8. PubMed ID: 6446011
    [No Abstract]   [Full Text] [Related]  

  • 3. Huntington's disease: treatment with muscimol, a GABA-mimetic drug.
    Shoulson I; Goldblatt D; Charlton M; Joynt RJ
    Ann Neurol; 1978 Sep; 4(3):279-84. PubMed ID: 152602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isoniazid-induced alteration of CSF neurotransmitter amino acids in Huntington's disease.
    Manyam BV; Ferraro TN; Hare TA
    Brain Res; 1987 Apr; 408(1-2):125-30. PubMed ID: 2885064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid GABA and homocarnosine concentrations in patients with Friedreich's ataxia, Parkinson's disease, and Huntington's chorea.
    Bonnet AM; Tell G; Schechter PJ; Grove J; Saint-Hilaire MH; De Smet Y; Agid Y
    Mov Disord; 1987; 2(2):117-23. PubMed ID: 2973560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Lumbar cerebrospinal fluid levels of GABA, HVA and 5HIAA in various patients with choreic movement and effects with isoniazid treatment].
    Yamamoto M; Otsuki S; Miyake K; Namba R
    No To Shinkei; 1983 May; 35(5):483-8. PubMed ID: 6194804
    [No Abstract]   [Full Text] [Related]  

  • 7. Letter: Low GABA levels in CSF in Huntington's chorea.
    Glaeser BS; Hare TA; Vogel WH; Olewiler DB; Beasley BL
    N Engl J Med; 1975 May; 292(19):1029-30. PubMed ID: 235093
    [No Abstract]   [Full Text] [Related]  

  • 8. GABA and movement disorders.
    Marsden CD; Sheehy MP
    Adv Biochem Psychopharmacol; 1981; 30():225-34. PubMed ID: 6460427
    [No Abstract]   [Full Text] [Related]  

  • 9. Huntington's Chorea and dimethylaminoethanol (deanol).
    Amsterdam JD; Dubin W
    J Clin Psychiatry; 1978 Jul; 39(7):626-8. PubMed ID: 150413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Choreic dyskinesia and GABA - pharmaco-clinical approach. Preliminary note].
    Roccatagliata G; Albano C; Besio G; Ivaldi EM
    Schweiz Arch Neurol Neurochir Psychiatr; 1978; 123(1):63-8. PubMed ID: 153581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal fluid acetylcholinesterase and choline measurements in Huntington's disease.
    Manyam BV; Giacobini E; Colliver JA
    J Neurol; 1990 Aug; 237(5):281-4. PubMed ID: 2146369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind clinical trial of isoniazid in Huntington disease.
    Perry TL; Wright JM; Hansen S; Thomas SM; Allan BM; Baird PA; Diewold PA
    Neurology; 1982 Apr; 32(4):354-8. PubMed ID: 6460947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma GABA predicts acute response to divalproex in mania.
    Petty F; Rush AJ; Davis JM; Calabrese JR; Kimmel SE; Kramer GL; Small JG; Miller MJ; Swann AE; Orsulak PJ; Blake ME; Bowden CL
    Biol Psychiatry; 1996 Feb; 39(4):278-84. PubMed ID: 8645774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human CSF GABA concentrations: revised downward for controls, but not decreased in Huntington's chorea.
    Perry TL; Hansen S; Wall RA; Gauthier SG
    J Neurochem; 1982 Mar; 38(3):766-73. PubMed ID: 6460090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevation of gamma-aminobutyric acid in human brain may increase dopaminergic neuronal function.
    Perry TL; Ito M; Jones K; Hansen S
    Neurosci Lett; 1984 Sep; 50(1-3):67-71. PubMed ID: 6238245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term continuous infusion of apomorphine hydrochloride for treatment of Huntington's chorea: A double blind, randomized cross-over trial.
    Vitale C; Marconi S; Di Maio L; De Michele G; Longo K; Bonavita V; Barone P
    Mov Disord; 2007 Dec; 22(16):2359-64. PubMed ID: 17894335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A controlled trial of remacemide hydrochloride in Huntington's disease.
    Kieburtz K; Feigin A; McDermott M; Como P; Abwender D; Zimmerman C; Hickey C; Orme C; Claude K; Sotack J; Greenamyre JT; Dunn C; Shoulson I
    Mov Disord; 1996 May; 11(3):273-7. PubMed ID: 8723144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of Huntington's chorea with isoniazid.
    Perry TL; MacLeod PM; Hansen S
    N Engl J Med; 1977 Oct; 297(15):840. PubMed ID: 142923
    [No Abstract]   [Full Text] [Related]  

  • 19. Isoniazid and Huntington's chorea.
    Roccatagliata G; Albano C
    N Engl J Med; 1978 Feb; 298(8):457. PubMed ID: 146161
    [No Abstract]   [Full Text] [Related]  

  • 20. Riluzole in Huntington's disease: a 3-year, randomized controlled study.
    Landwehrmeyer GB; Dubois B; de YĆ©benes JG; Kremer B; Gaus W; Kraus PH; Przuntek H; Dib M; Doble A; Fischer W; Ludolph AC;
    Ann Neurol; 2007 Sep; 62(3):262-72. PubMed ID: 17702031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.